Lixte Biotechnology Holdings Inc - ESG Rating & Company Profile powered by AI
The analysis of Lixte Biotechnology Holdings Inc incorporates information from across the internet as well as from available documents by Lixte Biotechnology Holdings Inc. This webpage is a zero-cost ESG report for Lixte Biotechnology Holdings Inc. The SDG rating for Lixte Biotechnology Holdings Inc represents the company's transparency towards the UN Sustainable Development Goals.
Lixte Biotechnology Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Lixte Biotechnology Holdings Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lixte Biotechnology Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc offer flexible work?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Lixte Biotechnology Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lixte Biotechnology Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lixte Biotechnology Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Lixte Biotechnology Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lixte Biotechnology Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lixte Biotechnology Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures, which might be useful in the treatment of cancers, and vascular and metabolic diseases; and LB-200 series for the treatment of chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and study with the National Cancer Institute. The company was founded in 2005 and is based in East Setauket, New York.